Artificial intelligence can help in the creation of new antibiotics
The use of artificial intelligence learning algorithms has led to the discovery of chemical structures that may be antibacterial without being toxic1
The use of artificial intelligence learning algorithms has led to the discovery of chemical structures that may be antibacterial without being toxic1
The Hospital Clínic-IDIBAPS Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer research team has described that the ZEB1 and1
The solidarity initiative promoted by Bonpreu and Esclat through the Worldcoo platform has raised €42,266, which will go towards endometriosis resear1
The Hospital Clínic-IDIBAPS, in collaboration with the Swiss-Catalan startup Zoundream AG, has conducted a study that lays the foundations for resear1
Dr. Joana Ferrer has led the working group that has established for the first time the clinical and research bases for the use of these devices in th1
The candidature of the Clínic-IDIBAPS researcher was approved with 90% of the votes at the general assembly of the European Association for the Study1
Pedro Luis Cepas has received one of the grants that the Daniel Bravo Andreu Private Foundation has awarded for research stays abroad.
Over the next five years, the project DynamHet will study the origin, evolution and function of heterogeneity presented by cancer-associated fibrobla1
On 1 January 2023, the unification of the scientific and management activities of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and1
On Tuesday, 17 January 2023, the IDIBAPS auditorium was the venue for the Second Conference on Good Practice of the Network of Tumour Banks of Catalo1